Economic Impact of Urinary Stones

Overview

Journal Transl Androl Urol

Date 2016 Jan 28

PMID 26816777

Citations 55

Authors

Elias S Hyams

Brian R Matlaga

Affiliations

Soon will be listed here.

Abstract

Kidney stones have been rising in prevalence in the United States and worldwide, and represent a significant cost burden. Cost effectiveness research in this area may enable improvements in treatment efficiency that can benefit patients, providers and the healthcare system. There has been limited research in the cost effectiveness of surgical interventions for stone disease, despite the diverse treatment approaches that are available. Medical expulsive therapy (MET) has been shown to improve rates of stone passage for ureteral stones, and there is evidence that this practice should be liberalized from the standpoint of both clinical and cost effectiveness. While conservative treatment following a primary stone event appears to be cost effective, the economic impact of medical therapy for recurrent stone formers requires clarification despite its clinical efficacy. Future study regarding the cost effectiveness of prevention and interventions for stone disease are likely to improve both the quality and efficiency of care.

Citing Articles

Exploring the Efficacy and Safety of Ketamine for Managing Acute Renal Colic in Emergency Departments: A Systematic Review of Recent Clinical Trials.

Sukhram S, Yilmaz G, Erichsen S, Vassilevich S Int J Mol Sci. 2025; 26(1.

PMID: 39796226 PMC: 11720103. DOI: 10.3390/ijms26010371.

The association between urinary lead concentration and the likelihood of kidney stones in US adults: a population-based study.

Liang D, Liu C, Yang M Sci Rep. 2025; 15(1):1653.

PMID: 39794487 PMC: 11723991. DOI: 10.1038/s41598-025-86086-9.

Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease.

Jiang G, Li S, Li H, Xie L, Li S, Yan Z World J Gastroenterol. 2024; 30(46):4914-4928.

PMID: 39679314 PMC: 11612713. DOI: 10.3748/wjg.v30.i46.4914.

Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease.

Byeon H World J Gastroenterol. 2024; 30(46):4977-4982.

PMID: 39679311 PMC: 11612707. DOI: 10.3748/wjg.v30.i46.4977.

Habitual tea consumption is associated with a lower prevalence of kidney stone disease in postmenopausal women.

Wu K, Lee J, Lee Y, Shen J, Wang H, Tsao Y PeerJ. 2024; 12:e18639.

PMID: 39677960 PMC: 11645981. DOI: 10.7717/peerj.18639.

References

Pearle M . Shock-wave lithotripsy for renal calculi. N Engl J Med. 2012; 367(1):50-7. DOI: 10.1056/NEJMct1103074. View

Matlaga B . Contemporary surgical management of upper urinary tract calculi. J Urol. 2009; 181(5):2152-6. DOI: 10.1016/j.juro.2009.01.023. View

Pearle M, Roehrborn C, Pak C . Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; 13(9):679-85. DOI: 10.1089/end.1999.13.679. View

Pearle M, Calhoun E, Curhan G . Urologic diseases in America project: urolithiasis. J Urol. 2005; 173(3):848-57. DOI: 10.1097/01.ju.0000152082.14384.d7. View

Lotan Y, Pearle M . Economics of stone management. Urol Clin North Am. 2007; 34(3):443-53. DOI: 10.1016/j.ucl.2007.04.008. View

Chu L, Farris C, Corcoran A, Averch T . Preoperative stent placement decreases cost of ureteroscopy. Urology. 2011; 78(2):309-13. DOI: 10.1016/j.urology.2011.03.055. View

Matlaga B, Jansen J, Meckley L, Byrne T, Lingeman J . Economic outcomes of treatment for ureteral and renal stones: a systematic literature review. J Urol. 2012; 188(2):449-54. PMC: 3787850. DOI: 10.1016/j.juro.2012.04.008. View

Akman T, Binbay M, Akcay M, Tekinarslan E, Kezer C, Ozgor F . Variables that influence operative time during percutaneous nephrolithotomy: an analysis of 1897 cases. J Endourol. 2011; 25(8):1269-73. DOI: 10.1089/end.2011.0061. View

Lotan Y . Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2008; 16(1):5-10. DOI: 10.1053/j.ackd.2008.10.002. View

10.

Lotan Y, Jimenez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I . Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int. 2012; 110(11 Pt C):E1060-7. DOI: 10.1111/j.1464-410X.2012.11212.x. View

11.

Fine J, Pak C, Preminger G . Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol. 1995; 153(1):27-32; discussion 32-3. DOI: 10.1097/00005392-199501000-00010. View

12.

Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

13.

Bensalah K, Pearle M, Lotan Y . Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol. 2007; 53(2):411-8. DOI: 10.1016/j.eururo.2007.09.012. View

14.

Curhan G . Epidemiology of stone disease. Urol Clin North Am. 2007; 34(3):287-93. PMC: 2693870. DOI: 10.1016/j.ucl.2007.04.003. View

15.

Hyams E, Munver R, Bird V, Uberoi J, Shah O . Flexible ureterorenoscopy and holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. J Endourol. 2010; 24(10):1583-8. DOI: 10.1089/end.2009.0629. View

16.

Lotan Y, Pearle M . Cost-effectiveness of primary prevention strategies for nephrolithiasis. J Urol. 2011; 186(2):550-5. DOI: 10.1016/j.juro.2011.03.133. View

17.

Saigal C, Joyce G, Timilsina A . Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?. Kidney Int. 2005; 68(4):1808-14. DOI: 10.1111/j.1523-1755.2005.00599.x. View

18.

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U . Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346(2):77-84. DOI: 10.1056/NEJMoa010369. View

19.

Jo Semins M, George S, Allaf M, Matlaga B . Ureteroscope cleaning and sterilization by the urology operating room team: the effect on repair costs. J Endourol. 2009; 23(6):903-5. DOI: 10.1089/end.2008.0489. View

20.

Raman J, Pearle M . Management options for lower pole renal calculi. Curr Opin Urol. 2008; 18(2):214-9. DOI: 10.1097/MOU.0b013e3282f517ea. View